科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
National Center for Cancer Immune Therapy,
Department of Oncology,
National Center for Cancer Immune Therapy, Department of Oncology
I am a Ph.d. student at the National Center for Cancer Immune Therapy at Herlev Hospital in Denmark.
MERTK Acts as a Costimulatory Receptor on Human CD8 T Cells.
Cancer immunology research Sep, 2019 | Pubmed ID: 31266785
TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
Cancer immunology, immunotherapy : CII Feb, 2020 | Pubmed ID: 31664482
TAM Receptor Inhibition-Implications for Cancer and the Immune System.
Cancers Mar, 2021 | Pubmed ID: 33801886
University Hospital Herlev
Kasper Mølgaard*,1,
Anne Rahbech*,1,
Özcan Met1,
Inge Marie Svane1,
Per thor Straten1,3,
Claus Desler2,
Marlies J. W. Peeters1
1National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev,
2Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen,
3Department of Immunology and Microbiology, Inflammation and Cancer Group, University of Copenhagen
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。